advertisement
11.4 Prostaglandins (16)
Showing records 1 to 16
Display all abstracts in classification 11.4 Prostaglandins
Search within classification 11.4 Prostaglandins24021 Assessing the efficacy of latanoprost vs timolol using an alternate efficacy parameter: the intervisit intraocular pressure range
Varma R; Hwang LJ; Grunden JW; Bean GW; Sultan MB
American Journal of Ophthalmology 2009; 148: 221-226
24193 Brimonidine tartrate 0.15%, dorzolamide hydrochloride 2%, and brinzolamide 1% compared as adjunctive therapy to prostaglandin analogs
Bournias TE; Lai J
Ophthalmology 2009; 116: 1719-1724
24058 A 12-week study evaluating the efficacy of bimatoprost 0.03% in patients with pseudoexfoliative and open-angle glaucoma
Ciancaglini M; Carpineto P; Agnifili L; Nubile M; Toto L; Mastropasqua L
European Journal of Ophthalmology 2009; 19: 594-600
24462 Considerations about administration angle of prostaglandin analogs
Estacia P; Tognon T
Arquivos Brasileiros de Oftalmologia 2008; 71: 684-688
24049 Cystoid macular oedema within 24 h after a single application of latanoprost
Grigoropoulos VG; Emfietzoglou I; Nikolaidis P; Theodossiadis PG; Theodossiadis GP
International Ophthalmology 2009; 29: 257-259
24270 The effect of travoprost 0.004% as an adjuvant to timolol 0.5% therapy
Kovacic Z; Stanic R; Rogosic V; Bojic L; Ivanisevic M; Capkun V
Acta Clinica Croatica, Supplement 2009; 48: 31-33
24282 A rare complication from prostaglandin analogue therapy
Mukhopadhyay R; Plumb A
Clinical and Experimental Optometry 2009; 92: 137-138
24091 A Prospective, randomized, investigator-masked evaluation of the monocular trial in ocular hypertension or open-angle glaucoma
Realini TD
Ophthalmology 2009; 116: 1237-1242
24262 Comparison of morning versus evening dosing and 24-h post-dose efficacy of travoprost compared with latanoprost in patients with open-angle glaucoma
Yan DB; Battista RA; Haidich A-B; Konstas AGP
Current Medical Research and Opinion 2008; 24: 3023-3027
24421 The impact of ocular adverse effects in patients treated with topical prostaglandin analogs: changes in prescription patterns and patient persistence
Zimmerman TJ; Hahn SR; Gelb L; Tan H; Kim EE
Journal of Ocular Pharmacology and Therapeutics 2009; 25: 145-152
24201 The prostanoid EP(2) receptor agonist ONO-AE1-259-01 protects against glutamate-induced neurotoxicity in rat retina
Mori A; Ishii T; Kuroki T; Shigeta N; Sakamoto K; Nakahara T; Ishii K
European Journal of Pharmacology 2009; 616: 64-67
24427 Dorzolamide/timolol combination versus latanoprost in the treatment of open-angle glaucoma: A systematic review
Ai Shan MLKM; Hadier J
Chinese Journal of Evidence-Based Medicine 2009; 9: 350-354
24053 Pneumatic trabeculoplasty vs latanoprost as adjunctive therapy to timolol in primary open-angle glaucoma or ocular hypertension
Uva MG; Longo A; Reibaldi M
Graefe's Archive for Clinical and Experimental Ophthalmology 2009; 247: 1103-1109
24256 First-year treatment patterns among new initiators of topical prostaglandin analogs
Schmier JK; Covert DW; Robin AL
Current Medical Research and Opinion 2009; 25: 851-858
24447 Cost-effectiveness of latanoprost, travoprost and bimatoprost for the treatment of glaucoma in Norway, Sweden and Denmark, using a decision-analytic health economic model
Stewart WC; Stewart JA; Mychaskiw MA
International Journal of Ophthalmology 2009; 9: 812-816
24130 Effects of latanoprost in iris bioidentification
Lamminen H; Voipio V; Manninen T; Huttunen H
Acta Ophthalmologica 2009; 87: 529-531
